InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: bluelucky post# 30873

Friday, 10/20/2017 2:13:24 PM

Friday, October 20, 2017 2:13:24 PM

Post# of 38634
Blue and Angelo- From the quarterly 6K:

{Cost of goods sold

The Company recorded cost of goods sold of $376,054 for the three months ended August 31, 2017 versus $Nil for the three months ended August 31, 2016. Cost of sales for the three months ended August 31, 2017, reflects the Company’s shipment of generic Seroquel XR® to Mallinckrodt launched in June 2017. As the product was launched in the current period, no cost of goods were recorded in the prior year.}

So $376K of Q3 was costs plus revenue mentioned above. That leaves $824K of revenue for both Focalin XR and Seroquel XR profit sharing. I venture to guess that Focalin XR accounted for 750K of that. That leaves 74K for Seroquel XR profits. Now say MNK sold $1.6M. That had at least a cost of the amount they paid IPCI. That leaves MNK with $1.22M. Well how much of that is profit? I would guess 60% or $732K. 74K is roughly 10% of that number.